MIT Enterprise Forum to Present Stem Cell Research Panel

Atlanta -

Will be broadcast to over 20 sites and

Atlanta – The MIT Enterprise Forum of Atlanta will present an expert panel addressing the often controversial topic of stem cells at its October 12, 2006 meeting. “The Promise of Stem Cells: Separating Hype from Reality” will address progress in the field of embryonic stem cell research and examine its influence on commercial applications in such industries as pharmacology, transgenics, biomedicine and cloning.

The program will be broadcast live and provided on DVD to other MIT Enterprise Forum sites globally, including Santiago, Chile; Manila, Philippines; and Warsaw, Poland. In the U.S., more than a dozen sites, stretching geographically from Seattle, Washington to Tampa, Florida, will view the panel presentation to get a clearer, non-politically infused perspective on the applications for stem cells, business opportunities, and research findings.

“The Promise of Stem Cells: Separating Hype from Reality” will feature noted researcher Dr. Steven L. Stice, professor and Georgia Research Alliance Eminent Scholar of Animal Reproductive Physiology, Director of UGA Regenerative Bioscience Center. Dr. Stice made history when he genetically engineered and cloned three calves from fetal cells. He also has participated in several biomed start-ups.

Joining him will be Dr. Michelle C. LaPlaca, associate professor, Department of Biomedical Engineering, Georgia Institute of Technology. Dr. LaPlaca is a pioneer in the study of traumatic brain and spinal cord injury, and tissue engineering of the injured nervous system.

Also participating in the panel discussion and serving as moderator will be Mr. David A. Dodd, former president, chief executive officer and director, Serologicals Corporation. Serologicals Corporation was recently acquired by bioscience company Millipore for $1.4 billion. Prior to its purchase, Serologicals supplied major health care companies with specialty biological products and related technologies used in the research, development, and manufacture of life science products.

Program attendees and viewers will learn:
· Where breakthroughs in stem cell research are projected and how they could lead to entrepreneurial business opportunities.
· The basics of stem cells, including the difference between adult stem cells and human embryonic stem cells, and how each figures in stem cell research;
· How stem cell research has contributed to advancements in drug discovery, treating cardiovascular diseases (heart and blood vessel repair), neurodegenerative disease such as Parkinson's, Alzheimer's and Multiple Sclerosis, and neural injuries like spinal cord and head trauma;
· How cloning and transgenics animal methodologies and platform technologies are leading to breakthroughs in biomedical and agricultural sciences;

The meeting will be held at the Georgia Public Broadcasting Auditorium. Networking will begin at 5:30 with the broadcast beginning at 7pm. Prices range from $25 for members to $45 for non-member onsite registration; all students are $10. Program participation and membership are open to all, regardless of academic affiliation. Additional information is available at

About The MIT Enterprise Forum

The MIT Enterprise Forum of Atlanta is a volunteer, not-for-profit organization whose mission is to provide educational programs and services that promote and strengthen innovation at the intersection of business and technology in the Southeast. Since the formation of the first chapter in Cambridge in 1978, The MIT Enterprise Forum has grown to a network of 24 chapters located both in the United States and abroad.